Lifecore Biomedical To Participate In Upcoming Investor Conferences
- Jefferies 2025 Global Healthcare Conference – London
Details: Paul Josephs, Lifecore's president and chief executive officer, will deliver a corporate presentation and Lifecore management will participate in investor meetings
Conference Dates: November 17-20, 2025
Presentation Time/Date: 9:30 – 9:55 a.m. Greenwich Mean Time (4:30 – 4:55 a.m. Eastern Time) on Tuesday, November 18, 2025, webcast available
Location: London, UK
- Stephens Annual Investment Conference
Details: Mr. Josephs will be a featured speaker in a fireside chat and Lifecore management will participate in 1-on-1 meetings
Conference Dates: November 18-20, 2025
Fireside Chat Time/Date: 9:00 – 9:45 a.m. Central Time on Thursday, November 20, 2025, webcast available
Location: Nashville
Webcasts of the Jefferies presentation and the Stephens fireside chat may be accessed via a link on Lifecore's investor website on the Investor Events & Presentations page at: . Additionally, replays of the webcasts will be available on the Lifecore website following the conference.
About Lifecore Biomedical
Lifecore Biomedical, Inc. (Nasdaq: LFCR ) is a fully integrated contract development and manufacturing organization (CDMO) that offers highly differentiated capabilities in the development, fill and finish of sterile injectable pharmaceutical products in syringes, vials, and cartridges, including complex formulations. As a leading manufacturer of premium, injectable-grade hyaluronic acid, Lifecore brings more than 40 years of expertise as a partner for global and emerging biopharmaceutical and biotechnology companies across multiple therapeutic categories to bring their innovations to market. For more information about the company, visit Lifecore's website at .

Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.

Comments
No comment